Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Michel Samson, Frédérick Libert, Benjamin J. Doranz et al. · Nature · 1996 · 2.9K citations

Life Sciences, Genetics, Molecular Genetics +11

Toxicity determined in vitro by morphological alterations and neutral red absorption

Ellen Borenfreund, James A. Puerner · Toxicology Letters · 1985 · 1.9K citations

Pharmacy, Biochemistry, Toxicology +4

Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

Beili Wu, Ellen Y. T. Chien, Clifford D. Mol et al. · Science · 2010 · 1.8K citations

Life Sciences, Molecular Biology, Oncology +17

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

Kaighn Me, Narayan Ks, Yuko Ohnuki et al. · PubMed · 1979 · 1.6K citations

Veterinary Medicine, Cell Biology, Oncology +17

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

Patrick Dorr, Mike Westby, Susan Dobbs et al. · Antimicrobial Agents and Chemotherapy · 2005 · 1.1K citations

Medicine, Medicinal Chemistry, Pharmacology +17